Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-003721

Sr. VP, Business Dev. gave up 6,416 shares (to pay taxes)

  • Sr. VP, Business Dev. acquired 20,305 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luu Brendan Sr. VP, Business Dev. 2023-02-13 Grant or award +8,945 34,670 D: show line 1 in the form
Luu Brendan Sr. VP, Business Dev. 2023-02-13 Grant or award +11,360 46,030 D: show line 2 in the form
Luu Brendan Sr. VP, Business Dev. 2023-02-13 Shares withheld for taxes −6,416 $52.77 $338,572 39,614 D: show line 3 in the form
Loading xslF345X03/form4.xml…